High and increasing prevalence of the uterine cancer is the major factor driving the global uterine cancer market |
Posted: July 23, 2019 |
Women of age between 42 and 50 experiencing menopause or post menopause, are more susceptible to be diagnosed and suffer through uterine cancer. It starts in the endometrium, which is a lining of uterus and proceeds to uterus and neighboring tissues and then to the whole body. Exact causes of the uterine cancer is still unknown and early diagnosis is roughly possible due to very common symptoms such as casual bleeding and others. Among four types of the uterine cancer, papillary serous carcinoma is most dangerous and aggressive as it tends to return even when it is diagnosed early and treated. Moreover, uterine sarcoma starts in the myometrium, uterine muscle wall and spreads to whole uterus and it tends to spread to lungs through bloodstream. High and increasing prevalence of the uterine cancer is the major factor driving the global uterine cancer market. According to the World Cancer Research Fund International, prevalence rate of the uterine cancer per 100,000 women is high across the globe in major countries including Belarus has 24.9 rate, Samoa has 24.8, Canada has 23.6, the U.S. 20.1, Poland has 19.1, Singapore has 19.1, Russia has 18.7, and Puerto Rico has 17.4. Ongoing research and development regarding diagnostics and treatment of the uterine cancer is the other factor which is expected to escalate the market growth during the forecast period 2019–2026. However, poor healthcare infrastructure across the Latin America and Africa is expected to restrain the market growth. Lack of advancements in the diagnostics in some region and scarcity of skilled diagnostics professionals are some of the other factors which are expected to hamper the market growth further. Unavailability of the reimbursement policies may slow the market growth during the forecast period 2019–2026. Read More about uterine cancer...
|
||||||||||||||||||
|